Through a proprietary technology, Dendris has innovated in the rapid capacity of identifying in a single assay a large broad spectrum of pathogens or biomarkers with high sensitivity and high specificity. Thus, Dendris brings into the Diagnostic field a new generation of molecular in vitro diagnostic (IVD) that largely overcomes the limits due to previous methods, including microbial PCR-based methods.